Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications.

Chitosan/tripolyphosphate/chondroitin sulfate (Chi/TPP/CS) nanoparticles were prepared by an ionic gelation method to obtain a controlled release of proteins. Using Nel-like molecule-1 (Nell-1), a novel osteogenic protein, as a model protein, it was demonstrated that adjusting the composition of the particles modulated the protein association and release kinetics of incorporated proteins. Increasing the amounts of Chi crosslinking agents, TPP and CS, in the particles achieved sustained protein release. An increase in crosslinking density decreased degradation rates of the particles. Furthermore, the bioactivity of the protein was preserved during the encapsulating procedure into the particles. To demonstrate the feasibility of Chi/TPP/CS nanoparticles as sustained release carriers for tissue engineering scaffold applications, protein-loaded nanoparticles were successfully incorporated into collagen hydrogels or prefabricated porous poly(lactide-co-glycolide) (PLGA) scaffolds without obstructing the integrity of the hydrogels or porous structure of the scaffolds. Thus, we expect that these particles have a potential for efficient protein carriers in tissue engineering applications, and will be further evaluated in vivo.

[1]  Y Ikada,et al.  In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. , 1997, Biomaterials.

[2]  D E Ingber,et al.  Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. , 1993, Journal of biomedical materials research.

[3]  W. Park,et al.  Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. , 1995, Biomaterials.

[4]  D. Chorvat,et al.  Chitosan based hydrogel microspheres as drug carriers. , 2007, Macromolecular Bioscience.

[5]  K. Powers,et al.  Physicochemical properties and blood compatibility of acylated chitosan nanoparticles , 2004 .

[6]  K. Janes,et al.  Polysaccharide colloidal particles as delivery systems for macromolecules. , 2001, Advanced drug delivery reviews.

[7]  Benjamin M. Wu,et al.  Modulation of protein delivery from modular polymer scaffolds. , 2007, Biomaterials.

[8]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[9]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[10]  Heungsoo Shin,et al.  Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. , 2007, Advanced drug delivery reviews.

[11]  C. P. Sharma,et al.  Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. , 1992, Biomaterials.

[12]  N. Selvamurugan,et al.  Chitosan and its derivatives for gene delivery. , 2011, International journal of biological macromolecules.

[13]  Tejraj M Aminabhavi,et al.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[14]  K. Draget,et al.  Chitosan cross-linked with Mo(VI) polyoxyanions: a new gelling system. , 1992, Biomaterials.

[15]  C. Remuñán-López,et al.  Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles , 1999, Pharmaceutical Research.

[16]  M. Alonso,et al.  Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .

[17]  A. Vila,et al.  Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[19]  K. Zhu,et al.  Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. , 2002, International journal of pharmaceutics.

[20]  Antonios G Mikos,et al.  Injectable matrices and scaffolds for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[21]  J. Brouwer,et al.  Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[22]  M. Longaker,et al.  Craniosynostosis in transgenic mice overexpressing Nell-1. , 2002, The Journal of clinical investigation.

[23]  R. Greenwald,et al.  Human cartilage lysozyme. , 1972, The Journal of clinical investigation.

[24]  J. Tessmar,et al.  Matrices and scaffolds for protein delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[25]  R Langer,et al.  Laminated three-dimensional biodegradable foams for use in tissue engineering. , 1993, Biomaterials.

[26]  Makarand V Risbud,et al.  Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. , 2005, Biomaterials.

[27]  Miqin Zhang,et al.  Chitosan-alginate hybrid scaffolds for bone tissue engineering. , 2005, Biomaterials.

[28]  Roland Bodmeier,et al.  Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films , 1997 .

[29]  H E Junginger,et al.  Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. , 2001, Biomaterials.

[30]  W. Risen,et al.  A spectroscopic and viscometric study of the metal ion-induced gelation of the biopolymer chitosan , 1997 .

[31]  V. Dodane,et al.  Pharmaceutical applications of chitosan , 1998 .

[32]  M. Longaker,et al.  Human NELL‐1 Expressed in Unilateral Coronal Synostosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.